Alzheimer's Disease and Frontotemporal Dementias

A Review with Particular Reference to Pin1 Protein

 

Home

Pin1 Protein

Our Research

Our TEM Research

Our Publications

Research Team

Alzheimer's Disease

Tauopathies

About this Site

Literature:   A-K ; L-Z ; subject area

Search Site by Subject Area

Disclaimer/ Feedback

Links

Compiled by: Julian Thorpe

 

Cytoskeleton

Please Note: Due to time constraints, the text part of this page has not been updated for some time. However, references are added reasonably frequently.

The disruption of the cytoskeleton is a key feature of AD, so here is some general background:
The cytoskeleton is a complex mixture of proteins which together act to maintain cell shape and facilitate the movement of particles and organelles within the cytoplasm. The overall cytoskeletal structure is very dynamic as the component proteins may go through rapid cycles of polymerisation and disassembly. These proteins may be broadly grouped into 3 types:

1. Microfilaments:

5-7nm thick filaments of F-actin which function as contractile elements when associated with the complementary contractile protein myosin (to form actinomyosin ). May also be laterally associated with other proteins and sometimes anchored to membranes.

2. Intermediate filaments:
N.B. See  Intermediate filaments of neural/glial cells for more detail on intermediate filaments specific to neurons and glial cells, research results, etc.
So named because of their intermediate size (c. 10nm) between the microfilaments and microtubules.
Contain a characteristic central alpha-helical domain that forms coiled-coil rods. The latter can assemble into filaments.
Responsible for cell shape maintenance and conferring some strength and rigidity.
The protein subunits of intermediate filaments show considerable diversity and tissue specificity.

Types:

Type I and II:keratins of epithelial cells.
Type III: vimentin (mesenchymal cells); desmin (muscle); glial fibrillary acidic protein (astroglia); peripherin (peripheral neurons)
Type IV: neurofilaments of neuronal cell types
Type V: nuclear lammins.

3. Microtubules:

They are c. 25nm in width and composed of tubulin .
Involved in the maintenance of cell shape and in the movement of organelles, cell products and chromosomes during cell division. They are also the components of cilia and flagella.
Play a crucial role in neuronal development as neuritic outgrowth is dependent upon microtubule assembly ( Yamada et al., 1970 ).
Microtubules and their associated proteins also form the basis of axonal transport.
The microtubules are associated with other proteins such as dynein and kinesin and also the MAPs ( microtubule-associated proteins ). Of the latter MAP1A and 1B (c. 350kD) and MAP2A and 2B (270kD) form projections from microtubules within brain cells. MAP2 is a distinguishing protein within axonal processes of neurones.
The MAP tau is as an elongated molecule (about 35-50 nm long, dependent on the isoform) without recognizable secondary structure ( Mandelkow et al., 1995). Its role may be likened to that of  'ties' which hold the microtubular tracks in place. There is a mixture of up to 6 isoforms in the human brain which are generated from a single gene by alternative splicing. Range in size from 352-441 amino acids ( Goedert et al., 1989). The recent finding that mutations in the tau gene are responsible for frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) has provided convincing evidence that tau protein plays a key role in neurodegeneration ( Hutton et al., 1998 ) and suggests that distinct sets of tau isoforms expressed in different neuronal populations could lead to different pathologies (see review: Buee et al., 2000 ). It appears to be enriched in axons, probably playing a role in axonal development, and it is the inappropriate hyperphosphorylation of this protein in AD which contributes towards neurofibrillary tangle development.

N.B. Please visit the website of the 'Institut National de la Sante et de la Recherche Medical' for detail on tau protein in relation to neurodegeneration

Some Related References

 

N.B. Free Medical Journals online now at : http://www.freemedicaljournals.com/
(These journals include: Neurology, Neurobiology of Disease, Journal of Neurochemistry, Alzheimer's Disease Review)

Abraha, A, Ghoshal, N, Gamblin, TC, Cryns, V, Berry, RW, Kuret, J and Binder, LI (2000) C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. JOURNAL OF CELL SCIENCE 113: 3737-3745

Ackerley, S, Thornhill, P, Grierson, AJ, Brownlees, J, Anderton, BH, Leigh, PN, Shaw, CE, Miller, CCJ (2003) Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. JOURNAL OF CELL BIOLOGY 161: 489-495

Adamec, E, Chang, HT, Stopa, EG, Hedreen, JC, Vonsattel, JP (2001) Tau protein expression in frontotemporal dementias. NEUROSCIENCE LETTERS 315: 21-24

Aletta_Jm, Shelanski_Ml, Greene_La. (1989) Phosphorylation Of The Peripherin 58-Kda Neuronal Intermediate Filament Protein - Regulation By Nerve Growth-Factor And Other Agents. JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, Vol.264, No.8, pp.4619- 4627

Anderson, SJ, Barker, PE, Hadfield, MG (2002) Cytonectin expression in Alzheimer disease. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 61: 230-236

Andorfer, CA and Davies, P (2000) PKA phosphorylations on tau: Developmental studies in the mouse. DEVELOPMENTAL NEUROSCIENCE 22: 303-309

Angelastro_JM, Ho_CL, Frappier_T, Liem_RKH, Greene_LA. (1998) Peripherin is tyrosine-phosphorylated at its carboxyl-terminal tyrosine. JOURNAL OF NEUROCHEMISTRY, 1998, Vol.70, No.2, pp.540-549

Arai, H, Ishiguro, K, Ohno, H, Moriyama, M, Itoh, N, Okamura, N, Matsui, T, Morikawa, Y, Horikawa, E, Kohno, H, Sasaki, H, Imahori, K (2000) CSF phosphorylated tau protein and mild cognitive impairment: a prospective study. EXPERIMENTAL NEUROLOGY 166: 201-203

Arai, Y, Yamazaki, M,  Mori, O, Muramatsu, H, Asano, G and Katayama, Y (2001) alpha-Synuclein-positive structures in cases with sporadic  Alzheimer's disease: morphology and its relationship to tau aggregation. BRAIN RESEARCH 888: 287-296

Arendt_T, Holzer_M, Fruth_R, Bruckner_MK, Gartner_U. (1998) Phosphorylation of tau, A beta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. NEUROBIOLOGY OF AGING, 1998, Vol.19, No.1, pp.3-13

Athlan_ES, Sacher_MG, Mushynski_WE. (1997) Associations between intermediate filament proteins expressed in cultured dorsal root ganglion neurons. JOURNAL OF NEUROSCIENCE RESEARCH, 1997, Vol.47, No.3, pp.300-310

Avila, J, Lucas, JL, Perez, M, Hernandez, F (2004) Role of tau protein in both physiological and pathological conditions. PHYSIOLOGICAL REVIEWS 84: 361-384

Avila, J, Lim, F, Moreno, F, Belmonte, C, Cuello, AC (2002) Tau function and dysfunction in neurons - Its role in neurodegenerative disorders. MOLECULAR NEUROBIOLOGY 25: 213-231

Atzori, C, Ghetti, B, Piva, R, Srinivasan, AN, Zolo, P, Delisle, MB, Mirra, SS, Migheli, A (2001) Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 60: 1190-1197

Bajo, M, Yoo, BC, Cairns, N, Gratzer, M, Lubec, G (2001) Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease. AMINO ACIDS 21: 293-301

Barghorn, S, Zheng-Fischhofer, Q, Ackmann, M, Biernat, J, von Bergen, M, Mandelkow, EM and Mandelkow, E (2000) Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. BIOCHEMISTRY 39: 11714-11721

Bendiske, J, Caba, E, Brown, QB, Bahr, BA (2002) Intracellular deposition, microtubule destabilization, and transport failure: An "early" pathogenic cascade leading to synaptic decline. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 61: 640-650

Bennecib, M, Gong, CX, Grundke-Iqbal, I and Iqbal, K (2000) Role of protein phosphatase-2A and-1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS LETTERS 485: 87-93

Bennett GS, Quintana R. (1997) Identification of Ser-Pro and Thr-Pro phosphorylation sites in chicken  neurofilament-M tail domain. J Neurochem, 1997 Feb, 68:2, 534-43

Benson_DL, Mandell_JW, Shaw_G, Banker_G. (1996) Compartmentation of alpha-internexin and neurofilament triplet  proteins in cultured hippocampal neurons. JOURNAL OF NEUROCYTOLOGY, 1996, Vol.25, No.3, pp.181-196

Brandt, R (2001) Cytoskeletal mechanisms of neuronal degeneration. CELL AND TISSUE RESEARCH 305: 255-265

Breen KC, Robinson PA, Wion D, Anderton BH. (1989) Partial sequence of the rat heavy neurofilament polypeptide (NF-H). Identification of putative phosphorylation sites. Published erratum appears in FEBS Lett 1989 Feb 27;244(2):509

Buee, L, Bussiere, T, Buee-Scherrer, V, Delacourte, A and Hof, PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. BRAIN RESEARCH REVIEWS 33: 95-130

Buee-Scherrer, V, Goedert, M (2002) Phosphorylation of micro tubule-associated protein tau by stress-activated protein kinases in intact cells. FEBS LETTERS 515: 151-154

Buerger, K, Teipel, SJ, Zinkowski, R, Blennow, K, Arai, H, Engel, R, Hofmann-Kiefer, K, McCulloch, C, Ptok, U, Heun, R, Andreasen, N, DeBernardis, J, Kerkman, D, Moeller, HJ, Davies, P, Hampel, H (2002) CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. NEUROLOGY 59: 627-629  

Cairns NJ, Lee V M-Y, Trojanowski JQ (2004) The cytoskeleton in neurodegenerative diseases (review article). Journal of Pathology 204: 438-449

Cairns NJ, Zhukareva V, Uryu K, Zhang B, Bigio E, Mackenzie IRA, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Lee VM-Y, Trojanowski JQ (2004) a-Internexin is Present in the Pathological Inclusions of Neuronal Intermediate Filament Inclusion Disease. Am J Pathol 164: 2153-2161 

Cash, AD, Aliev, G, Siedlak, SL, Nunomura, A, Fujioka, H, Zhu, XW, Raina, AK, Vinters, HV, Tabaton, M, Johnson, AB, Paula-Barbosa, M, Avila, J, Jones, PK, Castellani, RJ, Smith, MA, Perry, G (2003) Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. AMERICAN JOURNAL OF PATHOLOGY 162: 1623-1627

Chen, YH, He, RQ, Liu, Y, Liu, Y and Xue, ZG (2000) Effect of human neuronal tau on denaturation and reactivation of rabbit muscle D-glyceraldehyde-3-phosphate dehydrogenase. BIOCHEMICAL JOURNAL 351: 233-240

Chen XH, Meaney DF, Xu BN, Nonaka M, Mcintosh TK, Wolf JA, Saatman KE, Smith DH. (1999) Evolution of neurofilament subtype accumulation in axons following diffuse brain injury in the pig. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 58: 588-596

Chung, CW,  Song, YH, Kim, IK, Yoon, WJ, Ryu, BR,  Jo, DG, Woo, HN, Kwon, YK, Kim, HH,  Gwag, BJ,  Mook-Jung, IH and  Jung, YK (2001) Proapoptotic effects of Tau cleavage product generated by caspase-3. NEUROBIOLOGY OF DISEASE 8: 162-172

Citron, BA, SantaCruz, KS, Davies, PJA and Festoff, BW (2001) Intron-exon swapping of transglutaminase mRNA and neuronal tau aggregation in Alzheimer's disease. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 3295-3301

Conrad, C, Vianna, C, Freeman, M, Davies, P (2002) A polymorphic gene nested within an intron of the tau gene: Implications for Alzheimer's disease. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99: 7751-7756

Crowther, RA and Goedert, M (2000) Abnormal tau-containing filaments in neurodegenerative diseases. JOURNAL OF STRUCTURAL BIOLOGY 130: 271-279

Csokova, N, Skrabana, R, Liebig, HD, Mederlyova, A, Kontsek, P, Novak, M (2004) Rapid purification of truncated tau proteins: model approach to purification of functionally active fragments of disordered proteins, implication for neurodegenerative diseases. PROTEIN EXPRESSION AND PURIFICATION 35: 366-372

Daly, NL, Hoffmann, R, Otvos, L and Craik, DJ (2000) Role of phosphorylation in the conformation of tau peptides implicated in Alzheimer's disease. BIOCHEMISTRY 39: 9039-9046

David, DC, Layfield, R, Serpell, L, Narain, Y, Goedert, M, Spillantini, MG (2002)
Proteasomal degradation of tau protein
JOURNAL OF NEUROCHEMISTRY 83: 176-185

Davies, P, DeBernardis, J, Espinoza, M, Stahl, M and Vianna, C (2000) APP and tau phosphorylation in Alzheimer's disease. BRAIN PATHOLOGY 10: 493

Dehmelt, L, Halpain, S (2005) The MAP2/Tau family of microtubule-associated proteins.  GENOME BIOLOGY 6: 195-204

Dickson TC, King CE, McCormack GH, Vickers JC. (1999) Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease. EXPERIMENTAL NEUROLOGY 156: (1) 100-110 MAR 1999

Dowjat, WK, Wisniewski, H and Wisniewski, T (2001) Alzheimer's disease presenilin-1 expression modulates the assembly of neurofilaments. NEUROSCIENCE 103: 1-8

Eidenmuller, J, Fath, T, Hellwig, A, Reed, J, Sontag, E and Brandt, R (2000) Structural and functional implications of tau hyperphosphorylation: Information from phosphorylation-mimicking mutated tau proteins. BIOCHEMISTRY 39: 13166-13175

Eidenmuller, J, Fath, T, Maas, T, Pool, M, Sontag, E and Brandt, R (2001) Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein. BIOCHEMICAL JOURNAL 357: 759-767

Eliezer, D, Barre, P, Kobaslija, M, Chan, D, Li, XH, Heend, L (2005) Residual structure in the repeat domain of tau: Echoes of microtubule binding and paired helical filament formation. BIOCHEMISTRY 44: 1026-1036

ERRANTE_LD, WICHE_G, SHAW_G. (1994) DISTRIBUTION OF PLECTIN, AN INTERMEDIATE FILAMENT-ASSOCIATED  PROTEIN, IN THE ADULT-RAT CENTRAL-NERVOUS-SYSTEM. JOURNAL OF NEUROSCIENCE RESEARCH, 1994, Vol.37, No.4, pp.515-528

Esposito, G, Viglino, P, Novak, M and Cattaneo, A (2000) The solution structure of the C-terminal segment of tau protein. JOURNAL OF PEPTIDE SCIENCE 6: 550-559

Fan, QW, Yu, W, Senda, T, Yanagisawa, K and  Michikawa, M (2001) Cholesterol-dependent modulation of tau phosphorylation in cultured neurons. JOURNAL OF NEUROCHEMISTRY 76: 391-400

Feng, Y and  Walsh, CA (2001) Protein–Protein Interactions, Cytoskeletal Regulation And Neuronal Migration. Nature Reviews Neuroscience 2: 408 -416

Figlewicz DA, Rouleau GA, Krizus A, Julien JP. Polymorphism in the multi-phosphorylation domain of the human neurofilament heavy-subunit-encoding gene.

Forman, MS, Lee, VMY and Trojanowski, JQ (2001) New insights into genetic and molecular mechanisms of brain degeneration in tauopathies. JOURNAL OF CHEMICAL NEUROANATOMY 20: 225-244

Fountoulakis M,  Hardmeier R, Höger H and Lubec G (2001) Postmortem Changes in the Level of Brain Proteins. EXPERIMENTAL NEUROLOGY 167: 86-94

Friedhoff, P, von Bergen, M, Mandelkow, EM and Mandelkow, E (2000) Structure of tau protein and assembly into paired helical filaments. BIOCHIMICA ET BIOPHYSICA ACTA- MOLECULAR BASIS OF DISEASE 1502: 122-132

Fukuyama, R, Izumoto, T and Fushiki, S (2001) The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer's disease patients and correlates with severity of dementia. EUROPEAN NEUROLOGY 46: 35-38

Galvin_JE, Lee_VMY, Baba_M, Mann_DMA, Dickson_DW, Yamaguchi_H, Schmidt_ML, Iwatsubo_T, Trojanowski_JQ. (1997) Monoclonal antibodies to purified cortical lewy bodies recognize the mid-size neurofilament subunit.  ANNALS OF NEUROLOGY,1997, Vol.42, No.4, pp.595-603

Garcia, ML and Cleveland, DV (2001) Going new places using an old MAP: tau, microtubules and human neurodegenerative disease. CURRENT OPINION IN CELL BIOLOGY 13: 41-48

Geerts, H (1998) The tau protein in the pathophysiology of Alzheimer's disease. ALZHEIMERS REPORTS 1: S7-S8

Goedert, M, Ghetti, B, Spillantini, MG (2000) Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) - Their relevance for understanding the neurogenerative process. MOLECULAR BASIS OF DEMENTIA. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 920: 74-83

Goedert, M and Spillantini, MG (2000) Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease. BIOCHIMICA ET BIOPHYSICA ACTA- MOLECULAR BASIS OF DISEASE 1502: 110-121

Goedert, M., Spillantini, M.G., Jakes, R., Rutherford, D. and Crowther, R.A. (1989) Multiple isoforms of human microtubule-associated protein tau : sequences and localisation in neurofibrillary tangles of Alzheimer's disease. Neuron 3: 519-526

Goedert, M, Spillantini, MG, Serpell, LC, Berriman, J, Smith, MJ, Jakes, R, and Crowther, RA (2001) From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES 356: 213-227

Gotz, J (2001) Tau and transgenic animal models. BRAIN RESEARCH REVIEWS 35: 266-286

Gou_JP, Leterrier_J. (1995) Possible involvement of ubiquitination in neurofilament degradation. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, Vol.217, No.2, pp.529-538

Green, EK, Thaker, U, McDonagh, AM, Iwatsubo, T, Lambert, JC, Chartier-Harlin, MC, Harris, JM, Pickering-Brown, SM, Lendon, CL, Mann, DMA (2002) A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain. NEUROSCIENCE LETTERS 324: 113-116

Grierson, AJ, Johnson, GVW and Miller, CCJ (2001) Three different human tau isoforms and rat neurofilament light, middle and heavy chain proteins are cellular substrates for transglutaminase. NEUROSCIENCE LETTERS 298: 9-12

Hall, GF, Lee, VMY, Lee, G and Yao, J (2001) Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy. AMERICAN JOURNAL OF PATHOLOGY 158: 234-246

Hampel, H, Buerger, K, Kohnken, R, Teipel, SJ, Zinkowski, R, Moeller, HJ, Rapoport, SI and Davies, P (2001) Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231. ANNALS OF NEUROLOGY 49: 545-546

Hampel, H, Burger, K, Pruessner, JC, Zinkowski, R, DeBernardis, J, Kerkman, D, Leinsinger, G, Evans, AC, Davies, P, Moller, HJ, Teipel, SJ (2005) Correlation of cerebrospinal fluid levels of Tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. ARCHIVES OF NEUROLOGY 62: 770-773

Hampel, H, Buerger, K, Zinkowski, R, Teipel, SJ, Goernitz, A, Andreasen, N, Sjoegren, M, DeBernardis, J, Kerkman, D, Ishiguro, K, Ohno, H, Vanmechelen, E, Vanderstichele, H, McCulloch, C, Moller, HJ, Davies, P, Blennow, K (2004) Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease - A comparative cerebrospinal fluid study. ARCHIVES OF GENERAL PSYCHIATRY 61: 95-102

Hampel, H, Teipel, SJ (2004) Total and phosphorylated tau proteins: Evaluation as core biomarker candidates in frontotemporal dementia. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 17: 350-354

Haroutunian_V, Zhou_YL, Elder_G, Li_C, Lazzarini_RA. (1996) Age-dependent spatial memory deficits in transgenic mice expressing the human mid-sized neurofilament gene .1. MOLECULAR BRAIN RESEARCH, 1996, Vol.42, No.1, pp.62-70

Hashiguchi, M, Sobue, K and Paudel, HK (2000) 14-3-3 zeta is an effector of tau protein phosphorylation. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 25247-25254

Hashimoto_R, Nakamura_Y, Tsujio_I, Tanimukai_H, Kudo_T, Takeda_M. (1999) Quantitative analysis of neurofilament proteins in Alzheimer brain by enzyme linked immunosorbent assay system. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 1999, Vol.53, No.5, pp.587-591

Herrmann H and Aebi U (2000) Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr Opin Cell Biol 12: 79-90

Hiraoka, S, Yao, TM, Minoura, K, Tomoo, K, Sumida, M, Taniguchi, T, Ishida, T (2004) Conformational transition state is responsible for assembly of microtubule-binding domain of tau protein. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 315: 659-663

Hol, EM, Roelofs, RF, Moraal, E, Sonnemans, MAF, Sluijs, JA, Proper, EA, de Graan, PNE, Fischer, DF, van Leeuwen, FW (2003) Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms. MOLECULAR PSYCHIATRY 8: 786-796  

Hol, EM, van Dijk, R, Gerez, L, Sluijs, JA, Hobo, B, Tonk, MT, de Haan, A, Kamphorst, W, Fischer, DF, Benne, R, van Leeuwen, FW (2003) Frameshifted beta-amyloid precursor protein (APP(+1)) is a secretory protein, and the level of APP(+1) in cerebrospinal fluid is linked to Alzheimer pathology. JOURNAL OF BIOLOGICAL CHEMISTRY 278: 39637-39643

Holzer M, Holzapfel HP, Krohn K, Gertz HJ, Arendt T. (1999) Alterations in content and phosphorylation state of cytoskeletal proteins in the sciatic nerve during ageing and in Alzheimer's disease. JOURNAL OF NEURAL TRANSMISSION 106: (7-8) 743-755 1999

Horiguchi, T, Uryu, K, Giasson, BI, Ischiropoulos, H, LightFoot, R, Bellmann, C, Richter-Landsberg, C, Lee, VMY, Trojanowski, JQ (2003) Nitration of tau protein is linked to neurodegeneration in tauopathies. AMERICAN JOURNAL OF PATHOLOGY 163: 1021-1031

Hu, YY, He, SS, Wang, XC, Duan, QH, Grundke-Iqbal, I, Iqbal, K, Wang, JZ (2002) Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients – An ultrasensitive bienzyme-substrate-recycle enzyme-linked Immunosorbent assay. AMERICAN JOURNAL OF PATHOLOGY 160: 1269-1278

Hu, YY, He, SS, Wang, XC, Duan, QH, Khatoon, S, Iqbal, K, Grundke-Iqbal, I, Wang, JZ (2002) Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients. NEUROSCIENCE LETTERS 320: 156-160

Huc_C, Escurat_M, Djabali_K, Derer_M, Landon_F, Gros_F, Portier_MM. (1989) Phosphorylation Of Peripherin, An Intermediate Filament Protein, In Mouse Neuro-Blastoma Nie-115 Cell-Line And In Sympathetic Neurons. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, Vol.160, No.2, pp.772-779

Husseman, JW, Nochlin, D and Vincent, I (2000) Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases. NEUROBIOLOGY OF AGING 21: 815-828

Hutton, M (2000) Molecular genetics of chromosome 17 tauopathies. MOLECULAR BASIS OF DEMENTIA. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 920: 63-73

Hutton, M.; Lendon, C. L.; Rizzu, P.; Baker, M.; Froelich, S.; Houlden, H.; Pickering-Brown, S.; Chakraverty, S.; Isaacs, A.; Grover, A.; Hackett, J.; Adamson, J.; and 39 others: (1998) Association of missense and 5-prime-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702-705

Illenberger, S,  Zheng-Fischhofer, QY, Preuss, U, Stamer, K, Baumann, K, Trinczek, B, Biernat, J, Godemann, R,  Mandelkow, EM and Mandelkow, E (1998) The endogenous and cell cycle-dependent phosphorylation of tau  protein in living cells: Implications for Alzheimer's disease. MOLECULAR BIOLOGY OF THE CELL 9: 1495-1512

James_ND, Davis_DR, Sindon_J, Hanger_DP, Brion_JP, Miller_CCJ, Rosenberg_MP, Anderton_BH, Propst_F. (1996) Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine threonine kinase Mos. NEUROBIOLOGY OF AGING, 1996, Vol.17, No.2, pp.235-241

Johnstone_M, Goold_RG, Fischer_I, GordonWeeks_PR. (1997) The neurofilament antibody RT97 recognises a developmentally regulated phosphorylation epitope on microtubule-associated protein 1B. JOURNAL OF ANATOMY, 1997, Vol.191, No.Pt2, pp.229-244

Kampers, T, Pangalos, M, Geerts, H, Wiech, H and Mandelkow, E (1999) Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease. FEBS LETTERS 451: 39-44

Kanayama_G, Takeda_M, Niigawa_H, Ikura_Y, Tamii_H, Taniguchi_N, Kudo_T, Miyamae_Y, Morihara_T, Nishimura_T. (1996) The effects of repetitive mild brain injury on cytoskeletal protein and behavior. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1996, Vol.18, No.2, pp.105-115

Kar, S, Fan, J, Smith, MJ, Goedert, M, Amos, LA (2003) Repeat motifs of tau bind to the insides of microtubules in the absence of taxol. EMBO JOURNAL 22: 70-77

KARLSSON_JE, ROSENGREN_LE, HAGLID_KG. (1989) POLYCLONAL ANTISERA TO THE INDIVIDUAL NEUROFILAMENT TRIPLET PROTEINS - A CHARACTERIZATION USING ELISA AND IMMUNOBLOTTING. JOURNAL OF NEUROCHEMISTRY, 1989, Vol.53, No.3, pp.759-765

Kayyali_US, Zhang_W, Yee_AG, Seidman_JG, Potter_H. (1997) Cytoskeletal changes in the brains of mice lacking calcineurin A alpha. JOURNAL OF NEUROCHEMISTRY, 1997, Vol.68, No.4, pp.1668-1678

Kesavapany S, Patel V, Zheng YL, Pareek TK, Bjelogrlic M, Albers W, Amin N, Jaffe H, Gutkind JS, Strong MJ, Grant P, Pant HC (2007) Inhibition of Pin1 Reduces Glutamate-induced Perikaryal Accumulation of Phosphorylated Neurofilament-H in Neurons.
Mol Biol Cell.

Kim, DH, Koh, WK, Kim, JU, Lee, JH and Hong, HN (2001) Okadaic acid-induced upregulation of nitrotyrosine and heme oxygenase-1 in rat cortical neuron cultures. NEUROSCIENCE LETTERS 297: 33-36

King, ME, Ghoshal, N, Wall, JS, Binder, LI and Ksiezak-Reding, H (2001) Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments. AMERICAN JOURNAL OF PATHOLOGY 158: 1481-1490

Ko, LW, DeTure, M, Sahara, N, Chihab, R, Yen, SH (2002) Cellular models for tau filament assembly. JOURNAL OF MOLECULAR NEUROSCIENCE 19: 311-316

Kohnken, R, Buerger, K, Zinkowski, R, Miller, C, Kerkman, D, DeBernardis, J, Shen, JF, Moller, HJ, Davies, P, Hampel, H (2000) Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients. NEUROSCIENCE LETTERS 287: 187-190

Kondratick, CM and Vandre, DD (1996) Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes. JOURNAL OF NEUROCHEMISTRY 67: 2405-2416

Kong J and Xu Z (2000)  Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis.  Neurosci Lett 281: 72-4

Ksiezak-Reding, H, He, DK, Gordon-Krajcer, W, Kress, Y, Lee, S and Dickson, DW (2000) Induction of Alzheimer-specific tau epitope AT100 in apoptotic human fetal astrocytes. CELL MOTILITY AND THE CYTOSKELETON 47: 236-252

Kvetnoy, IM, Hernandez-Yago, J, Kvetnaia, TV, Khavinson, VK, Malinin, VV, Yarilin, AA, Sharova, NI, Blesa, JR, Anisimov, VN, Lenskaia, LV, Sluchevskaia, SF, Chekalina, SI, Tokarev, OY and Yuzhakov, V (2000) Tau-protein expression in human blood lymphocytes: a promising marker and suitable sample for life-time diagnosis of Alzheimer's disease. NEUROENDOCRINOLOGY LETTERS 21: 313-318

Lee, VMY, Goedert, M and Trojanowski, JQ (2001) Neurodegenerative tauopathies. ANNUAL REVIEW OF NEUROSCIENCE 24: 1121-1159

Lee VM, Otvos L Jr, Carden MJ, Hollosi M, Dietzschold B, Lazzarini RA. Identification of the major multiphosphorylation site in mammalian neurofilaments.

Lewis, J, McGowan, E, Rockwood, J, Melrose, H, Nacharaju, P, Van Slegtenhorst, M, Gwinn-Hardy, K, Murphy, MP, Baker, M, Yu, X, Duff, K, Hardy, J, Corral, A, Lin, WL, Yen, SH, Dickson, DW, Davies, P and Hutton, M (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. NATURE GENETICS 25: 402-405

Lian, QY, Ladner, CJ, Magnuson, D and Lee, JM (2001) Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex. EXPERIMENTAL NEUROLOGY 167: 158-165

LIBERSKI_PP, BUDKA_H, YANAGIHARA_R, GAJDUSEK_DC. (1995) NEUROAXONAL DYSTROPHY IN EXPERIMENTAL CREUTZFELDT-JAKOB-DISEASE - ELECTRON-MICROSCOPIC AND IMMUNOHISTOCHEMICAL DEMONSTRATION OF NEUROFILAMENT ACCUMULATIONS WITHIN AFFECTED NEURITES. JOURNAL OF COMPARATIVE PATHOLOGY, 1995, Vol.112, No.3, pp.243- 255

Lichtenberg-Kraag B, Mandelkow EM, Biernat J, Steiner B, Schroter C, Gustke N, Meyer HE, Mandelkow E. Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau.

Liu, SJ, Fang, ZY, Yang, Y (2002) Activation of glycogen sythase kinase-3 induces in vivo Alzheimer-like hyperphosphorylation of cytoskleteton proteins and special memory impairment in rats. FASEB JOURNAL 16: A546

Lucas, JL, Hernandez, F, Gomez-Ramos, P, Moran, MA, Hen, R and Avila, J (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3 beta conditional transgenic mice. EMBO JOURNAL 20: 37-39

Luo, MH, Tse, SW, Memmott, J, Andreadis, A (2004) Novel isoforms of tau that lack the microtubule-binding domain. JOURNAL OF NEUROCHEMISTRY 90: 340-351

Maas, T, Eidenmuller, J, Brandt, R (2000) Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 15733-15740

Mack, TGA, Dayanandan, R, Van Slegtenhorst, M, Whone, A, Hutton, M, Lovestone, S, Anderton, BH (2001) Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells. NEUROSCIENCE 108: 701-712

Mailliot, C, Bussiere, T, Hamdane, M, Sergeant, N, Caillet, ML, Delacourte, A, Buee, L (2000) Pathological tau phenotypes - The weight of mutations, polymorphisms, and differential neuronal vulnerabilities. MOLECULAR BASIS OF DEMENTIA. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 920: 107-114

Makrides, V, Shen, TE, Bhatia, R, Smith, BL, Thimm, J, Lal, R, Feinstein, SC (2003) Microtubule-dependent oligomerization of tau - Implications for physiological tau function and tauopathies. JOURNAL OF BIOLOGICAL CHEMISTRY 278: 33298-33304

Mandelkow E; Song YH; Schweers O; Marx A; Mandelkow EM. (1995) On the structure of microtubules, tau, and paired helical filaments.Neurobiol Aging, 1995 May, 16:3, 347-54

Mandelkow, EM, Stamer, K, Biernat, J, Trinczek, B, von Bergen, M and Mandelkow, E (2001) Tau protein and Alzheimer's disease: aggregation; phosphorylation; and role in axonal traffic and neurite outgrowth. JOURNAL OF NEUROCHEMISTRY 77: S0102

Martin, GM (2000) Molecular mechanisms of late life dementias. EXPERIMENTAL GERONTOLOGY 35: 439-443

Miller, CCJ, Ackerley, S, Brownlees, J, Grierson, AJ, Jacobsen, NJO, Thornhill, P (2002) Axonal transport of neurofilaments in normal and disease states. CELLULAR AND MOLECULAR LIFE SCIENCES 59: 323-330

Minamide, LS, Striegl, AM, Boyle, JA, Meberg, PJ and Bamburg, JR (2000) Neurodegenerative stimuli induce persistent ADF/cofilin-actin rods that disrupt distal neurite function. NATURE CELL BIOLOGY 2: 628-636

Minoura, K, Tomoo, K, Ishida, T, Hasegawa, H, Sasaki, M, Taniguchi, T (2002) Amphipathic helical behavior of the third repeat fragment in the tau microtubule-binding domain, studied by H-1 NMR spectroscopy. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 294: 210-214

Mitchell, TW, Nissanov, J, Han, LY, Mufson, EJ, Schneider, JA, Cochran, EJ, Bennett, DA, Lee, VMY, Trojanowski, JQ and Arnold, SE (2000) Novel method to quantify neuropil threads in brains from elders with or without cognitive impairment. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY 48: 1627-1637

Mookherjee, P, Johnson, GVW (2001) Tau phosphorylation during apoptosis of human SH-SY5Y neuroblastoma cells. BRAIN RESEARCH 921: 31-43

Morris, HR, Khan, MN, Janssen, JC, Brown, JM, Perez-Tur, J, Baker, M, Ozansoy, M, Hardy, J, Hutton, M, Wood, NW, Lees, AJ, Revesz, T, Lantos, P, Rossor, MN (2001) The genetic and pathological classification of familial frontotemporal dementia. ARCHIVES OF NEUROLOGY 58: 1813-1816

Mosaheb S, Thorpe JR, Hashemzadeh-Bonehi L, Bigio EH, Gearing M, Cairns NJ (2005) Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease (NIFID). Acta Neuropathologica 110: 360-368 

Mudher, A, Lovestone, S (2002) Alzheimer's disease - do tauists and baptists finally shake hands? TRENDS IN NEUROSCIENCES 25: 22-26

Mukaetova-Ladinska, EB, Garcia-Siera, F, Hurt, J, Gertz, HJ, Xuereb, JH, Hills, R, Brayne, C, Huppert, FA, Paykel, ES, McGee, M, Jakes, R, Honer, WG, Harrington, CR and Wischik, CM (2000) Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. AMERICAN JOURNAL OF PATHOLOGY 157: 623-636

Nagiec, EE, Sampson, KE and Abraham, I (2001) Mutated tau binds less avidly to microtubules than wildtype tau in living cells. JOURNAL OF NEUROSCIENCE RESEARCH 63: 268-275

Nagy, Z (2000b) Cell cycle regulatory failure in neurones: causes and consequences. NEUROBIOLOGY OF AGING 21: 761-769

Nakamura_Y, Hasimoto_R, Kashiwagi_Y, Miyamae_Y, Shinosaki_K, Nishikawa_T, Hattori_H, Kudo_T, Takeda_M. (1997) Abnormal distribution of neurofilament L in neurons with Alzheimer's disease. NEUROSCIENCE LETTERS, 1997, Vol.225, No.3, pp.201-204

Nakayama, T, Sawada, T (2002) Involvement of microtubule integrity in memory impairment caused by colchicine. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 71: 119-138

Neely, MD, Swift, LL and Montine, TJ (2000) Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules. LIPIDS 35: 1249-1257

Olivieri, G, Baysang, G, Meier, F, Muller-Spahn, F, Stahelin, HB, Brockhaus, M and Brack, C (2001) N-acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on beta-amyloid secretion and tau phosphorylation. JOURNAL OF NEUROCHEMISTRY 76: 224-233

Oron_L, Dubovik_V, Novitsky_L, Eilam_D, Michaelson_DM. (1997) Animal model and in vitro studies of anti neurofilament antibodies mediated neurodegeneration in Alzheimer's disease. JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1997, No.49, pp.77-84

Pathan, N, Aime-Sempe, C, Kitada, S, Haldar, S and Reed, JC (2001) Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1. NEOPLASIA 3: 70-79

Perez, M, Arrasate, M, de Garcini, EM, Munoz, V and Avila, J (2001) In vitro assembly of tau protein: Mapping the regions involved in filament formation. BIOCHEMISTRY 40: 5983-5991

Perez, M, Hernandez, F, Gomez-Ramos, A, Smith, M, Perry, G, Avila, J (2002) Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. EUROPEAN JOURNAL OF BIOCHEMISTRY 269: 1484-1489

Pickering-Brown, SM, Richardson, AMT, Snowden, JS, McDonagh, AM, Burns, A, Braude, W, Baker, M, Liu, WK, Yen, SH, Hardy, J, Hutton, M, Davies, Y, Allsop, D, Craufurd, D, Neary, D, Mann, DMA (2002) Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. BRAIN 125: 732-751

Pigino, G, Pelsman, A, Mori, H and Busciglio, J (2001) Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation. JOURNAL OF NEUROSCIENCE 21: 834-842

Pollak, D, Cairns, N, Lubec, G (2003) Cytoskeleton derangement in brain of patients with Down Syndrome, Alzheimer's disease and Pick's disease. JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT 67: 149-158

Poorkaj, P, Grossman, M, Steinbart, E, Payami, H, Sadovnick, A, Nochlin, D, Tabira, T, Trojanowski, JQ, Borson, S, Galasko, D, Reich, S, Quinn, B, Schellenberg, G and Bird, TD (2001) Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. ARCHIVES OF NEUROLOGY 58: 383-387

Poorkaj, P, Kas, A, D'Souza, I, Zhou, Y, Pham, Q, Stone, M, Olson, MV and Schellenberg, GD (2001) A genomic sequence analysis of the mouse and human microtubule-associated protein tau. MAMMALIAN GENOME 12: 700-712

Rademakers, R, Cruts, M, van Broeckhoven, C (2004) The role of tau (MAPT) in frontotemporal dementia and related tauopathies. HUMAN MUTATION 24: 277-295

Rank, KB, Pauley, AM, Bhattacharya, K, Wang, ZG, Evans, DB, Fleck, TJ, Johnston, JA, Sharma, SK (2002) Direct interaction of soluble human recombinant tau protein with A beta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II. FEBS LETTERS  514: 263-268

Rapoport, M, Dawson, HN, Binder, LI, Vitek, MP, Ferreira, A (2002) Tau is essential to beta-amyloid-induced neurotoxicity. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99: 6364-6369

Ray SK, Fidan M, Nowak MW, Wilford GG, Hogan EL and  Banik NL (2000) Oxidative stress and Ca2+ influx upregulate calpain and induce apoptosis in PC12 cells. Brain Res 852: 326-34

Reynolds, MR, Berry, RW, Binder, LI (2005) Site-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: Implications for Alzheimer's disease. BIOCHEMISTRY 44: 1690-1700

Rosengren_LE, Karlsson_JE, Karlsson_JO, Persson_LI, Wikkelso_C. (1996) Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. JOURNAL OF NEUROCHEMISTRY, 1996, Vol.67, No.5, pp.2013-2018

Rosengren_LE, Karlsson_JE, Sjogren_M, Blennow_K, Wallin_A. (1999) Neurofilament protein levels in CSF are increased in dementia. NEUROLOGY, 1999, Vol.52, No.5, pp.1090-1093

Rub, U, Del Tredici, K, Schultz, C, Thal, DR, Braak, E and Braak, H (2000) The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 26: 553-567

Russ, C, Powell, JF, Zhao, JH, Baker, M, Hutton, M, Crawford, F, Mullan, M, Roks, G, Cruts, M, Lovestone, S (2001) The microtubule associated protein Tau gene and Alzheimer's disease - an association study and meta-analysis. NEUROSCIENCE LETTERS 314: 92-96

Sadqi, M, Hernandez, F, Pan, UM, Perez, M, Schaeberle, MD, Avila, J, Munoz, V (2002) alpha-helix structure in Alzheimer's disease aggregates of tau-protein. BIOCHEMISTRY 41: 7150-7155

Saito, Y and Murayama, S (2000) Expression of tan immunoreactivity in the spinal motor neurons of Alzheimer's disease. NEUROLOGY 55: 1727-1729

Sanchez, I, Hassinger, L, Sihag, RK, Cleveland, DW, Mohan, P and Nixon, RA (2000) Local control of neurofilament accumulation during radial growth of myelinating axons in vivo: Selective role of site-specific phosphorylation. JOURNAL OF CELL BIOLOGY 151: 1013-1024

Sato, Y, Naito, Y, Grundke-Iqbal, I, Iqbal, K and Endo, T (2001) Analysis of N-glycans of pathological tau: possible occurrence of aberrant processing of tau in Alzheimer's disease. FEBS LETTERS 496: 152-160

Schultz, C, Hubbard, GB, Rub, U, Braak, E and Braak, H (2000) Age-related progression of tau pathology in brains of baboons. NEUROBIOLOGY OF AGING 21: 905-912

Schwab, C, DeMaggio, AJ, Ghoshal, N, Binder, LI, Kuret, J and McGeer, PL (2000) Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative disease. NEUROBIOLOGY OF AGING 21: 503-510

Sengupta, A, Kabat, J, Novak, M, Wu, QL, Grundke-Iqbal, I and Iqbal, K (1998) Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubule. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 357: 299-309

Shea_TB, Husain_T. (1995) Inhibition of proteolysis enhances aluminum-induced perikaryal neurofilament accumulation but does not enhance tau accumulation. MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1995, Vol.26, No.3, pp.195-212

Sheng, JG, Jones, RA, Zhou, XQ, McGinness, JM, Van Eldik, LJ, Mrak, RE, Griffin, WST (2001) Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. NEUROCHEMISTRY INTERNATIONAL 39: 341-348

Shepherd, CE, McCann, H, Thiel, E, Halliday, GM (2002) Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies. NEUROBIOLOGY OF DISEASE 9: 249-257

Shepherd, CE, Thiel, E, McCann, H and Halliday, GM (2001) Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease. NEUROBIOLOGY OF DISEASE 8: 136-146

Shevtsov, PN (2001) Microtubules system in pathogenesis and treatment of Alzheimer's disease. JOURNAL OF NEUROCHEMISTRY 77: P0137

Shukla, C and Bridges, LR (2001) Tau, beta-amyloid and beta-amyloid precursor protein distribution in the entorhinal-hippocampal alvear and perforant pathways in the Alzheimer's brain. NEUROSCIENCE LETTERS 303: 193-197

Shim, KS, Lubec, G (2002) Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome. NEUROSCIENCE LETTERS 324: 209-212

Sjogren, M, Davidsson, P, Gottfries, J, Vanderstichele, H, Edman, A, Vanmechelen, E, Wallin, A and Blennow, K (2001) The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 12: 257-264

Sjogren, M, Davidsson, P, Tullberg, M, Minthon, L, Wallin, A, Wikkelso, C, Granerus, AK, Vanderstichele, H, Vanmechelen, E and Blennow, K (2001) Both total and phosphorylated tau are increased in Alzheimer's disease. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 70: 624-630

Sjögren M, Rosengren L, Minthon L, Davidsson P, Blennow K and Wallin A (2000) Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD. Neurology 54: 1960-1964

Smith DH, Chen XH, Nonaka M, Trojanowski JQ, Lee VMY, Saatman KE, Leoni MJ, Xu BN, Wolf JA, Meaney DF. (1999) Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 58: (9) 982-992 SEP 1999

SMITH_MC, MALLORY_M, HANSEN_LA, GE_NF, MASLIAH_E. (1995) FRAGMENTATION OF THE NEURONAL CYTOSKELETON IN THE LEWY BODY VARIANT OF ALZHEIMERS-DISEASE. NEUROREPORT, 1995, Vol.6, No.4, pp.673-676

SMITH_MA, RUDNICKANAWROT_M, RICHEY_PL, PRAPROTNIK_D, MULVIHILL_P, MILLER_CA, SAYRE_LM, PERRY_G. (1995) CARBONYL-RELATED POSTTRANSLATIONAL MODIFICATION OF NEUROFILAMENT PROTEIN IN THE NEUROFIBRILLARY PATHOLOGY OF ALZHEIMERS-DISEASE JOURNAL OF NEUROCHEMISTRY, 1995, Vol.64, No.6, pp.2660-2666

Sobue, K, Agarwal-Mawal, A, Li, W, Sun, W, Miura, Y and Paudel, HK (2000) Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 16673-16680

Spittaels, K, Van den Haute, C, Van Dorpe, J, Bruynseels, K, Vandezande, K, Laenen, I, Geerts, H, Mercken, M, Sciot, R, Van Lommel, A, Loos, R and Van Leuven, F (1999) Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. AMERICAN JOURNAL OF PATHOLOGY 155: 2153-2165

Spittaels, K, Van den Haute, C, Van Dorpe, J, Geerts, H, Mercken, M, Bruynseels, K, Lasrado, R, Vandezande, K, Laenen, I, Boon, T, Van Lint, J, Vandenheede, J, Moechars, D, Loos, R and Van Leuven, F (2000) Glycogen synthase kinase-3 beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 41340-41349

Stamer, K, Vogel, R, Thies, E, Mandelkow, E, Mandelkow, EM (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. JOURNAL OF CELL BIOLOGY 156: 1051-1063

Steinert_PM. (1996) Intermediate filaments in health and disease. EXPERIMENTAL AND MOLECULAR MEDICINE, 1996, Vol.28, No.2, pp.55- 63

STRONG_MJ, MAO_K, NERURKAR_VR, WAKAYAMA_I, YANAGIHARA_R, GARRUTO_RM. (1994) DOSE-DEPENDENT SELECTIVE SUPPRESSION OF LIGHT (NFL) AND MEDIUM  (NFM) BUT NOT HEAVY (NFH) MOLECULAR-WEIGHT NEUROFILAMENT MESSENGER-RNA LEVELS IN ACUTE ALUMINUM NEUROTOXICITY. MOLECULAR AND CELLULAR NEUROSCIENCE, 1994, Vol.5, No.4, pp.319-326

Su_JH, Cummings_BJ, Cotman_CW. (1996) Plaque biogenesis in brain aging and Alzheimer's disease .1. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments BRAIN RESEARCH, 1996, Vol.739, No.1-2, pp.79-87

Sun, W, Qureshi, HY, Cafferty, PW, Sobue, K, Agarwal-Mawal, A, Neufield, KD, Paudel, HK (2002) Glycogen synthase kinase-3,beta is complexed with tau protein in brain microtubules. JOURNAL OF BIOLOGICAL CHEMISTRY 277: 11933-11940

Sych, M, Hartmann, H, Steiner, B and Mueller, WE (2000) Presenilin I interaction with cytoskeleton and association with actin filaments. NEUROREPORT 11: 3091-3098

Tanemura, K, Akagi, T, Murayama, M, Kikuchi, N, Murayama, O, Hashikawa, T, Yoshiike, Y, Park, JM, Matsuda, K, Nakao, S, Sun, XY, Sato, S, Yamaguchi, H, Takashima, A (2001) Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau. NEUROBIOLOGY OF DISEASE 8: 1036-1045

Tanemura, K, Murayama, M, Akagi, T, Hashikawa, T, Tominaga, T, Ichikawa, M, Yamaguchi, H, Takashima, A (2002) Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. JOURNAL OF NEUROSCIENCE 22: 133-141

Terwel, D, Dewachter, I, Van Leuven, F (2002) Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease . NEUROMOLECULAR MEDICINE 2: 151-165

Tesseur, I, Van Dorpe, J, Spittaels, K, Van den Haute, C, Moechars, D and Van Leuven, F (2000) Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. AMERICAN JOURNAL OF PATHOLOGY 156: 951-964

Thorpe, J.R., Morley, S.J. and Rulten, S.L. (2001) Utilising the Peptidyl-Prolyl Cis-Trans Isomerase Pin1 as a Probe of its Phosphorylated Target Proteins: Examples of Binding to Nuclear Proteins in a Human Kidney Cell Line and to Tau in Alzheimer’s Diseased Brain. J. Histochem. Cytochem. 49: 97-108

Tolnay, M, Spillantini, MG, Rizzini, C, Eccles, D, Lowe, J and Ellison, D (2000) A new case of frontotemporal dementia and parkinsonism resulting from an intron 10+3-splice site mutation in the tau gene: clinical and pathological features. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 26: 368-378

Tomizawa, K, Omori, A, Ohtake, A, Sato, K and Takahashi, M (2001) Tau-tubulin kinase phosphorylates tau at Ser-208 and Ser-210, sites found in paired helical filament-tau. FEBS LETTERS 492: 221-227

Trojanowski, JQ, Lee, VMY (2002) The role of tau in Alzheimer's disease. MEDICAL CLINICS OF NORTH AMERICA 86: 615-629

Van Slegtenhorst M, Lewis J and Hutton M (2001) The molecular genetics of the tauopathies. Exp Gerontol 2000 Jul;35(4):461-71

Vijayan, S, El-Akkad, E, Grundke-Iqbal, I, Iqbal, K (2001) A pool of beta-tubulin is hyperphosphorylated at serine residues in Alzheimer disease brain. FEBS LETTERS 509: 375-381

Walsh, DM, Selkoe, DJ (2004) Oligomers in the brain: The emerging role of soluble protein aggregates in neurodegeneration. PROTEIN AND PEPTIDE LETTERS 11: 213-228

Wang, YP, Wang, JZ (2002) Detection of mRNA level and mutation of neurofilament in Alzheimer's disease. FASEB JOURNAL 16: A505

Wei, Q, Holzer, M, Brueckner, MK, Liu, Y, Arendt, T (2002) Dephosphorylation of tau protein by calcineurin triturated into neural living cells. CELLULAR AND MOLECULAR NEUROBIOLOGY 22: 13-24

Wen, Y, Yang, SH, Liu, R, Simpkins, JW (2004) Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. BRAIN RESEARCH 1022: 30-38

Yamada, K.M., Spooner, B.S. and Wessels, M.K. (1970) Axon growth: role of microfilaments and microtubules. Proc. Natl. Acad. Sci USA 66: 1206-1212

Yamamoto, H, Yamauchi, E, Taniguchi, H, Ono, T, Miyamoto, E (2002) Phosphorylation of microtubule-associated protein tau by Ca2+/calmodulin-dependent protein kinase II in its tubulin binding sites . ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 408: 255-262

Yoshiyama, Y, Zhang, B, Bruce, J, Trojanowski, JQ, Lee, VMY (2003) Reduction of detyrosinated Microtubules and Golgi fragmentation are linked to tau-induced degeneration in astrocytes. JOURNAL OF NEUROSCIENCE 23: 10662-10671

Yu, WH and Fraser, PE (2001) S100 beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease. JOURNAL OF NEUROSCIENCE 21: 2240-2246

Zhang, JW and Johnson, GVW (2000) Tau protein is hyperphosphorylated in a site-specific manner in apoptotic neuronal PC12 cells. JOURNAL OF NEUROCHEMISTRY 75: 2346-2357

Zhang, YJ, Xu, YF, Chen, XQ, Wang, XC, Wang, JZ (2005) Nitration and oligomerization of tau induced by peroxynitrite inhibit its microtubule-binding activity. FEBS LETTERS 579: 2421-2427

Zhou XZ, Kops O, Werner A, Lu PJ, Shen M, Stoller G, Kullertz G, Stark M, Fischer G and Lu KP (2000) Pin1-dependent prolyl isomerisation regulates dephosphorylation of Cdc25C and tau proteins. Molecular Cell 6: 873-883